Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Medclair

2.30 SEK

0.00 %

Less than 1K followers

MCLR

Nordic SME

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
-6.88 %
-17.86 %
-22.82 %
-21.50 %
+52.32 %
+84.00 %
+34.19 %
-19.46 %

Medclair is a Swedish cleantech company that develops technology for sustainable handling of nitrous oxide in healthcare, recycling and other industries using nitrous oxide. The company has an established international presence and offers solutions that aim to both reduce climate impact and improve the working environment. The headquarters are located in Stockholm.

Read more
Market cap
210.79M SEK
Turnover
23.76K SEK
Revenue
52.08M
EBIT %
9.86 %
P/E
38.33
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7/5
2026

Interim report Q1'26

20/8
2026

Interim report Q2'26

5/11
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types
Regulatory press release4/2/2026, 6:00 AM

Rättelse: Medclair - Årsredovisning 2025

Medclair
Regulatory press release4/1/2026, 3:31 PM

Medclair - Årsredovisning 2025

Medclair
Regulatory press release4/1/2026, 3:31 PM

Medclair - Annual Report 2025

Medclair

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release3/31/2026, 11:45 AM

Medclair säkrar dubbla patent för ny teknik inom lustgashantering

Medclair
Press release3/31/2026, 11:45 AM

Medclair secures dual patents for new technology in nitrous oxide management

Medclair
Regulatory press release3/23/2026, 10:35 AM

Medclair erhåller kompletteringsorder om 5,4 MSEK

Medclair
Regulatory press release3/23/2026, 10:35 AM

Medclair receives follow-on order of SEK 5.4 million

Medclair
Regulatory press release3/20/2026, 11:15 AM

Kallelse till årsstämma i Medclair AB (publ)

Medclair
Regulatory press release3/20/2026, 11:15 AM

Notice of Annual General Meeting in Medclair AB (publ)

Medclair
Press release3/11/2026, 11:20 AM

Medclair säkrar strategiskt USA-patent för bärbar lustgasdetektor

Medclair
Press release3/5/2026, 8:31 AM

Medclair inleder samarbete med ledande europeisk återvinningsaktör

Medclair
Press release3/3/2026, 7:15 AM

Medclairs lösningar lyfts i nationell branschdialog på Irland

Medclair
Press release2/19/2026, 11:30 AM

Medclair Presentation av bokslutskommuniké 2025 är nu live

Medclair
Regulatory press release2/19/2026, 11:20 AM

Rättelse: Medclair: Bokslutskommuniké 2025

Medclair
Regulatory press release2/18/2026, 6:00 PM

Medclair genomför en riktad emission om cirka 22,9 MSEK till den institutionella investeraren Eiffel Investment Group

Medclair
Regulatory press release2/18/2026, 5:30 PM

Medclair: Bokslutskommuniké 2025

Medclair
Press release2/18/2026, 11:00 AM

Medclair: Presentation av Bokslutskommuniké 2025

Medclair
Press release2/2/2026, 7:00 AM

Medclair stärker sin position i Frankrike – genombrottsorder inom återvinning

Medclair
Press release1/23/2026, 7:00 AM

Medclair tecknar distributörsavtal med Sedeer Medical i Qatar

Medclair
Press release1/21/2026, 7:00 AM

Medclair accelererar global expansion med lanseringen av EXPO.p

Medclair
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.